Distinct virologic trajectories in chronic hepatitis B identify heterogeneity in response to nucleos(t)ide analogue therapy (JHEP Reports, 2024)

(untitled) - Wang, T; Campbell, C; Stockdale, AJ; Todd, S; McIntyre, K; Frankland, A; Jaworski, J; Glampson, B; Papadimitriou, D; Mercuri, L; Mayer, E; Jones, CR; et al.